Abatement approval paves way for Covance jobs
The Hancock County Council this morning unanimously approved a tax-incentive agreement that should lead Covance Inc. to add
315 jobs at its Greenfield Laboratories.
The Hancock County Council this morning unanimously approved a tax-incentive agreement that should lead Covance Inc. to add
315 jobs at its Greenfield Laboratories.
Eli Lilly and Co. has reorganized its venture capital division and simultaneously poured in an additional $25 million.
Hill-Rom Holdings Inc. topped analysts’ expectations in its fiscal third
quarter even as hospital-spending cuts clipped its revenue by 9 percent, the company announced late yesterday.
If one of the more liberal health care reform proposals becomes law, Hoosier taxpayers would have to spend $425 more per
person every year for the next decade, according to a study released Aug. 4 by Florida-based conservative policy group Arduin
Laffer & Moore Econometrics.
In the eyes of Scott Law, Congress is heading in exactly the wrong direction on health care reform.
But the
CEO of Zotec Partners predicts a big bump in sales for his physician-billing management company if current reform proposals
become law.
A panel of five leaders of the state’s life sciences
industry took on a wide range of topics
July 24 at IBJ’s Power Breakfast
at the Westin Indianapolis.
More emerging life science companies have found life in the form of federal
Small Business Innovation Research grants.
Conseco Inc. recorded profit at the high-end of its preliminary
estimates, the company announced today.
Indianapolis-based Eli Lilly and Co. today said it is offering buyouts to its U.S. sales force,
with hopes of trimming about 300 sales representatives before a sales restructuring set to begin in January, Reuters reported.
Midland, Mich.-based Dow Chemical Co. is still considering divesting Indianapolis subsidiary Dow AgroSciences LLC. But
chances that the chemical manufacturing giant will sell its local agricultural chemical and biotech unit appear to have decreased.
Investors in a company built around clinical research software bought from Eli Lilly and Co. have found their exit, though
it’s far from the lucrative payoff they’d once imagined.
Carmel-based Dormir LLC’s announcement July 29 of $12 million in venture financing was the second local life sciences
deal announced in July. It could suggest a turnaround from a woeful second-quarter performance, when Indiana life
sciences firms announced zero venture capital deals.
The CEO of Indianapolis-based Arcadia Resources said the environment is perfect for his company’s fast-growing DailyMed
service.
Eli Lilly and Co. has blasted past analysts’ earnings projections for two straight quarters. But if Lilly officials
take that as a sign they can breathe easier, they need only flip through a stack of Wall Street research reports on the company.
Midland, Mich.-based Dow Chemical Co. is still considering divesting Indianapolis subsidiary Dow AgroSciences LLC. But chances
that the chemical manufacturing giant will sell its local agricultural chemical and biotech unit have decreased.
Shares of Conseco Inc. soared today in response to the company’s preliminary report of second-quarter profits. The Carmel-based
insurer’s stock price jumped as much as 53 percent, to $2.91, before settling a bit in the afternoon.
Carmel-based Dormir Inc., which operates sleep study centers and sleep equipment stores around the country, raised $12 million
in venture capital from three out-of-state firms. The company plans use the proceeds to acquire six to 10 companies this year
and more next year, according to CEO Tim Miller.
Indianapolis-based Dow AgroSciences LLC will have a new CEO after its parent organization moves Jerome Peribere into a new
position, the company announced today. Antonio Galindez, 54, vice president of Dow AgroSciences’ crops business, will step
into the top job.
WellPoint Inc. shares slipped in morning trading after the company beat analysts’ expectations for second-quarter profits
but failed to raise its year-end earnings forecast. WellPoint earned $1.50 per share in the latest quarter, excluding investment
losses. Analysts were expecting $1.43 per share, according to a survey by Thomson Financial Network.
Baldwin & Lyons Inc. said today that its profit last quarter was the second-highest in company
history, as investment gains from recovering equity markets helped boost performance.